In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta(TM) mice and c-myc/lacZ double transgenic mice

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 356, Issue 2, 1996, Pages 287-296

  Davis, Cindy D ^a   Dacquel, Emelyn J ^a   Schut, Herman A J ^b   Thorgeirsson, Snorri S ^a   Snyderwine, Elizabeth G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

2 Amino 3,8 dimethylimidazo 4,5 f quinoxaline; 2 Amino 3 methylimidazo 4.5 f quinoline; 2 Amino 9H pyrido 2,3 b indole; 32P postlabeling; In vivo mutagenicity

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; HETEROCYCLIC AMINE; INDOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; GENE EXPRESSION; IN VIVO STUDY; LIVER MICROSOME; MALE; METABOLIC ACTIVATION; MOUSE; MUTAGENESIS; MUTAGENICITY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0030599151     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(96)00074-7     Document Type: Article

References (32)

1. Ames, B.N., J. McCann and E. Yamasaki (1975) Methods for detecting carcinogens and mutagens with the Salmonella/ mammalian microsome mutagenicity test. Mutation Res., 31, 347-364.
2. Davis, C.D, H.A.J. Schut, R.H. Adamson, U.P. Thorgeirsson, S.S. Thorgeirsson and E.G. Snyderwine (1993a) Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo. Carcinogenesis, 14, 61-65.
3. Davis, C.D., R.H. Adamson and E.G. Snyderwine (1993b) Studies on the mutagenic activation of heterocyclic amines by cynomolgus monkeys, rat and human microsomes show that cynomolgus monkeys have a low capacity to N-oxidize the quinoxaline-type heterocyclic amines. Cancer Lett., 73, 95-104.
4. ™ Mouse and positive selection for LacZ -phage. Mutagenesis, 9, 183-185.
5. Doll, R. and D. Peto (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 66, 1191-1208.
6. Endo, H., H.A.J. Schut and E.G. Snyderwine (1994) Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system. Cancer Res., 54, 3745-3751.
7. Endo, H., H.A.J. Schut and E. Snyderwine (1995) Distribution of the DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF gene as determined by a polymerase arrest assay with thermal cycle sequencing. Mol. Carcinogen., 14, 198-204.
8. Felton, J.S. and M.G. Knize (1991) Occurrence, identification and bacterial mutagenicity of heterocyclic amines in cooked food. Mutation Res., 259, 205-217.
9. Gossen, J. A. and J. Vijg (1993) A selective system for lacZ phage using a galactose-sensitive E. coli host. Biotechniques, 14, 324-325.
10. Gossen, J.A, W.J.F. de Leeuw C.H.T. Tan, E.C. Zwarthoff, F. Berends, P.H.M. Lohman, D.L. Knook and J. Vijg (1989) Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. USA, 86, 7971-7985.
11. - plasmids. Nucleic Acids Res., 20, 3254.
12. Gross, G.A. and A. Grüter (1992) Quantitation of mutagenic/carcinogenic heterocyclic aromatic amines in food products. J. Chromatogr., 592, 271-278.
13. Harris. C.C. (1991) Chemical and physical Carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51, 5023s-5044s.
14. Kohler, S.W., G.S. Provost, A. Fieck, P.L. Kretz, W.O. Bullock, J.A. Sorge, D.L. Putman and J.M. Short (1991) Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. USA, 88, 7958-7962.
15. Lowry, O.H., N.J. Rosenbrough, A.L. Farr and R.J. Randall (1951) Protein measurements with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
16. - phages based on galactose sensitivity. Transgenic Res., 3, 67-69.
17. Murakami, H., N.D. Sanderson, P. Nagy, P.A. Marino, G. Merlino and S.S. Thorgeirsson (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor a in hepatic oncogenesis. Cancer Res., 53, 1719-1723.
18. Oghaki, H., K. Kusama, N. Matsukura, K., Morino H. Hasegawa, S. Sato, S. Takayama and T. Sugimura (1984a) Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis, 5, 921-924.
19. Oghaki, H., N. Matsukura, K. Morino, T. Kawachi, T. Sugimura and S. Takayama (1984b) Carcinogenicity in mice of mutagenic compounds from glutamic acid and soybean globulin pyrolysates. Carcinogenesis, 5, 815-819.
20. Oghaki, H., H. Hasegawa, M. Suenaga, Sato, S., S. Takayama and T. Sugimura (1987) Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis, 8, 665-668.
21. 32P-Postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,1 2-dimethylbenz[a]anthracene. Carcinogenesis, 6, 1117-1126.
22. SAS Institute Inc. (1989) SAS User's Guide: Statistics, Version 4 (4th Edn.), Statistical Analysis System Institute, Gary, NC, pp. 891-896.
23. Schut, H.A.J., P.J. Wirth and S.S. Thorgeirsson (1978) Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat. Mol. Pharmacol., 14, 682-692.
24. Schut, H.A.J., K.L. Putman and K. Randerath (1988) DNA adduct formation of the carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in target tissues of the F-344 rat. Cancer Lett., 41, 345-352.
25. 32P-Postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx-and PhIP-treated monkeys. Carcinogenesis, 14, 1389-1395.
26. Sugimura, T. (1982) Mutagens, carcinogens and tumor promoters in our daily food. Cancer, 49, 1970-1980.
27. Sugimura, T. (1985) Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutation Res., 150, 33-41.
28. - transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses. Mutation Res., 307, 169-173.
29. Turesky, R.J. and J. Markovic (1995) DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in liver, kidney and colo-rectum of rats. Carcinogenesis, 16, 2275-2279.
30. Ushijima, T., Y. Hosoya, M. Ochiai, H. Kushida, K. Wakabayashi, T. Suzuki, M. Hayashi, T. Sofuni, T. Sugimura and M. Nagao (1994) Tissue-specific mutational spectra of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in the liver and bone marrow of lacI transgenic mice. Carcinogenesis, 15, 2805-2809.
31. Watanabe, M. and T. Ohta (1993) Analysis of mutational specificity induced by heterocyclic amines in the lacZ gene of Escherichia coli. Carcinogenesis, 14, 1149-1153.
32. Yamashita, K., M. Adachi, S. Kato, H. Nakagama, M. Ochiai, K. Wakabayashi, S. Sato, M. Nagao and T. Sugimura (1990) DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration. Jpn. J. Cancer Res., 81, 470-476.